Kaplan S L, Grumbach M M
Acta Endocrinol (Copenh). 1976 Apr;81(4):808-29. doi: 10.1530/acta.0.0810808.
The content and concentrations of immunoreactive LH (LER-960) and FSH (LER-869) were determined in 79 human foetal pituitary glands from 68 days of gestation to term, and in the pituitary glands of 3 anencephalic infants, 10 infants and children 2 weeks to 7 years of age, and 4 adults. In addition, the concentration of immunoreactive serum LH, FSH, LH-HCG, and HCG was determined in 48 foetuses and 6 anencephalic infants. The mean content of LH in the pituitary glands of the female foetuses increased sharply from 88.2 +/- 44.2 ng at 10 to 14 weeks to 4983.8 +/- 1128.4 ng at 25 to 29 weeks of gestation. In the male foetuses, the mean content of pituitary LH rose from levels of 21.0 +/- 11.6 ng to peak levels of 114.5 +/- 57.1 ng at 20 to 24 weeks of gestation. The concentration of LH in the pituitary glands of the children was comparable to that of foetuses at mid-gestation. The mean content of FSH in pituitary glands of female foetuses rose from 7.4 +/- 5.2 ng at 10 to 14 weeks to 4788.6 +/- 1460.7 ng at 25 to 29 weeks of gestation. In the male foetuses the pituitary content rose from 1.8 +/- 0.7 ng at 10 to 14 weeks to 14.5 +/- 69.1 ng at 25 to 29 weeks of gestation. The differences in pituitary content of LH and FSH between the male and female foetuses were highly significant from 15 to 29 weeks of gestation. The correlation of the incremental changes in the pituitary content of LH and FSH with gestational age was significant (P less than 0.02). Immunoreactive serum FSH was detected as early as 84 days of gestation at a concentration of 11.0 ng/ml (LER-869). Serum FSH rose to peak levels (18.2 +/- 3.6 ng/ml) at 20 to 25 weeks in a range comparable to that of castrate adults. A decrease was noted by 30 to 34 weeks to levels of 1.7 +/- 0.05 ng/ml, comparable to that in cord samples at term (1.8 +/- 0.2 ng/ml). A significant negative correlation with gestational age was shown after the mid-gestational period (P less than 0.01). Immunoreactive LH, measured by a specific LH assay, was unaffected by levels of HCG present in the foetus. Immunoreactive LH was present in high concentrations by 99 days of gestation (21.5 ng/ml LER-960). Peak levels were attained by 100 to 180 days of gestation with a decrease at them to less than 1.0 ng/ml. A significant negative correlation was noted between serum LH and gestational age. Serum HCG quantified in a betaHCG radioimmunoassay decreased from the relatively high levels in foetuses at 90 to 120 days gestational age to term. The mean concentration in umbilical cord sera was 268.5 +/- 161 mIU/ml in contrast to 5400 +/- 200 mIU/ml in maternal plasma at term. ...
在79例从妊娠68天至足月的人胎儿垂体以及3例无脑儿、10例2周龄至7岁婴幼儿和4例成人的垂体中,测定了免疫反应性促黄体生成素(LER-960)和促卵泡生成素(LER-869)的含量及浓度。此外,还测定了48例胎儿和6例无脑儿血清中免疫反应性促黄体生成素、促卵泡生成素、促黄体生成素-人绒毛膜促性腺激素及人绒毛膜促性腺激素的浓度。女性胎儿垂体中促黄体生成素的平均含量从妊娠10至14周时的88.2±44.2纳克急剧升至妊娠25至29周时的4983.8±1128.4纳克。男性胎儿垂体中促黄体生成素的平均含量从10至14周时的21.0±11.6纳克升至妊娠20至24周时的峰值114.5±57.1纳克。儿童垂体中促黄体生成素的浓度与妊娠中期胎儿的相当。女性胎儿垂体中促卵泡生成素的平均含量从10至14周时的7.4±5.2纳克升至妊娠25至29周时的4788.6±1460.7纳克。男性胎儿垂体中促卵泡生成素的含量从10至14周时的1.8±0.7纳克升至妊娠25至29周时的14.5±69.1纳克。妊娠15至29周期间,男性和女性胎儿垂体中促黄体生成素和促卵泡生成素含量的差异极为显著。促黄体生成素和促卵泡生成素垂体含量的增量变化与胎龄的相关性显著(P<0.02)。早在妊娠84天时就能检测到免疫反应性血清促卵泡生成素,浓度为11.0纳克/毫升(LER-869)。血清促卵泡生成素在20至25周时升至峰值水平(18.2±3.6纳克/毫升),与去势成人的水平相当。到30至34周时有所下降,降至1.7±0.05纳克/毫升,与足月时脐带血样本中的水平相当(1.8±0.2纳克/毫升)。妊娠中期之后与胎龄呈显著负相关(P<0.01)。通过特定的促黄体生成素测定法测得的免疫反应性促黄体生成素不受胎儿体内人绒毛膜促性腺激素水平的影响。妊娠99天时免疫反应性促黄体生成素的浓度就很高(21.5纳克/毫升LER-960)。在妊娠100至180天时达到峰值水平,之后降至低于1.0纳克/毫升。血清促黄体生成素与胎龄之间呈显著负相关。在β-人绒毛膜促性腺激素放射免疫测定中定量的血清人绒毛膜促性腺激素从妊娠90至120天时胎儿体内的相对高水平降至足月时。足月时脐带血清中的平均浓度为268.5±161毫国际单位/毫升;相比之下,足月时母体血浆中的浓度为5400±200毫国际单位/毫升。……